Fig. 5From: Silymarin modulates catabolic cytokine expression through Sirt1 and SOX9 in human articular chondrocytesNAM attenuated the therapeutic effects of SMN, as evidenced by the downregulation of Sirt-1, AGCN and COL2A1Back to article page